MedTrace Logo

Preschooler Emotion Regulation in the Context of Maternal Borderline Personality Disorder

NCT03060902 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 93

Last updated 2024-01-12

Study results available
· View outcomes & findings →

Summary

Offspring of mothers with Borderline Personality Disorder (BPD) are at serious risk for developing mental illness at every stage of their life, and yet little is known about how this risk is transmitted. This study will leverage Dialectical Behavior Therapy Skills as an experimental intervention to determine if preschool emotion regulation develops more rapidly as a result of improvements in mothers' ability to regulate her own emotions. The knowledge from this study will identify a modifiable pathway by which maternal BPD places offspring at risk for later mental disorders and will quantify how much improvement in children's ability to regulate their emotions can be achieved by treating mothers alone.

Conditions

  • Borderline Personality Disorder
  • Emotional Problem

Interventions

BEHAVIORAL

Dialectical Behavior Therapy Skills

DBT Skills Training will follow the DBT Skills Training Manual Second Edition and the DBT Skills Training Handouts and Worksheets Second Edition.

Sponsors & Collaborators

  • University of Pittsburgh

    collaborator OTHER

  • University of Oregon

    lead OTHER

Principal Investigators

  • Maureen Zalewski, Ph.D. · University of Oregon

  • Stephanie Stepp, Ph.D. · University of Pittsburgh

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-10-23
Primary Completion
2022-05-04
Completion
2022-05-04

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03060902 on ClinicalTrials.gov